(RTTNews) - Enlivex Therapeutics Ltd.(ENLV), a biotechnology company developing therapies for age-related inflammatory conditions, announced positive 12-month topline results from the Phase IIa stage of its Phase I/IIa trial evaluating Allocetra in patients with moderate-to-sever